Search by Drug Name or NDC
NDC 00409-1159-02 BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL Details
BUPIVACAINE HYDROCHLORIDE 2.5 mg/mL
BUPIVACAINE HYDROCHLORIDE is a EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is BUPIVACAINE HYDROCHLORIDE.
Product Information
NDC | 00409-1159 |
---|---|
Product ID | 0409-1159_a33878a1-9d68-4a46-9913-c7be85f1d1ff |
Associated GPIs | 69100010102007 |
GCN Sequence Number | 052193 |
GCN Sequence Number Description | bupivacaine HCl/PF VIAL 2.5 MG/ML INJECTION |
HIC3 | H0A |
HIC3 Description | LOCAL ANESTHETICS |
GCN | 19757 |
HICL Sequence Number | 025243 |
HICL Sequence Number Description | BUPIVACAINE HCL/PF |
Brand/Generic | Generic |
Proprietary Name | BUPIVACAINE HYDROCHLORIDE |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | bupivacaine hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | INJECTION, SOLUTION |
Route | EPIDURAL; INFILTRATION; INTRACAUDAL; PERINEURAL |
Active Ingredient Strength | 2.5 |
Active Ingredient Units | mg/mL |
Substance Name | BUPIVACAINE HYDROCHLORIDE |
Labeler Name | Hospira, Inc. |
Pharmaceutical Class | Amide Local Anesthetic [EPC], Amides [CS], Local Anesthesia [PE] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA070583 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00409-1159-02 (00409115902)
NDC Package Code | 0409-1159-02 |
---|---|
Billing NDC | 00409115902 |
Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-1159-02) / 30 mL in 1 VIAL, SINGLE-DOSE (0409-1159-19) |
Marketing Start Date | 2005-08-15 |
NDC Exclude Flag | N |
Pricing Information | N/A |